Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

Condition:   Pancreatic CancerInterventions:   Biological: GVAX Pancreas;   Biological: CRS-207;   Drug: CyclophosphamideSponsors:   Aduro BioTech, Inc.;   Johns Hopkins UniversityActive, not recruiting - verified May 2014

Source: ClinicalTrials.gov - August 10, 2011 Category: Research Source Type: clinical trials